structure_inline_fullcolor_rgb_12in@300ppi.png
Structure Therapeutics Announces $300 Million Private Placement Equity Financing
29 sept. 2023 07h32 HE | Structure Therapeutics Inc.
$300 million financing includes significant participation from a number of large healthcare dedicated institutional and mutual fund investors Net proceeds, along with existing cash, cash equivalents...
structure_inline_fullcolor_rgb_12in@300ppi.png
Structure Therapeutics Announces Positive Results from Phase 1b Clinical Study of Oral GLP-1 Receptor Agonist GSBR-1290 and Provides Program Update
29 sept. 2023 07h30 HE | Structure Therapeutics Inc.
GSBR-1290 shown to be generally well-tolerated with no adverse event-related discontinuations in Phase 1b multiple ascending dose study Significant weight loss at 28 days supporting once-daily...
Hennessy Capital Investment Corp. VI Announces Postponement of its Special Meeting of Stockholders to 3 P.M. ET on September 29
29 sept. 2023 01h07 HE | Hennessy Capital Investment Corp. VI
New York, NY, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Hennessy Capital Investment Corp. VI (NASDAQ: HCVI) (the “Company”) today announced that its special meeting of the stockholders (the “Meeting”)...
FirstLight_Logo.png
Calidi Biotherapeutics Debuts as a Publicly Traded Company Focused on Arming the Immune System to Fight Cancer with a New Generation of Targeted Immunotherapies
13 sept. 2023 05h50 HE | First Light Acquisition Group
Business combination transaction with First Light Acquisition Group, a special purpose acquisition company, completed on September 12, 2023 Gross proceeds made available to Calidi Biotherapeutics...
FirstLight_Logo.png
First Light Acquisition Group Announces NYSE Approval for Listing of Business Combination with Calidi Biotherapeutics and Additional New Capital Commitments
11 sept. 2023 16h05 HE | First Light Acquisition Group
Business combination transaction with Calidi Biotherapeutics anticipated to be completed on September 12, 2023 Gross proceeds made available to Calidi Biotherapeutics from transaction will total...
hairmax-icon-black+V2.jpg
Hairmax® Appoints Francisco Cestero as Chief Financial Officer
07 sept. 2023 08h59 HE | Hairmax
BOCA RATON, Fla., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Hairmax, the pioneer and global leader in transformation hair growth, announced today the appointment of Francisco Cestero, as Chief Financial...
ASRELogo.png
Astra Energy Inc. Announces Spin-Out of Regreen Technologies Inc.
06 sept. 2023 09h00 HE | Astra Energy Inc.
SAN DIEGO, Sept. 06, 2023 (GLOBE NEWSWIRE) -- via IBN -- Astra Energy Inc. (OTCQB: ASRE) (“Astra” or the “Company”) is pleased to announce that its Board of Directors unanimously approved a...
99 Acquisition Group Inc. Announces Pricing of $75,000,000 Initial Public Offering
17 août 2023 21h09 HE | 99 Acquisition Group Inc.
GAITHERSBURG, MD, Aug. 17, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – 99 Acquisition Group Inc. (the "Company") announced today that it priced its initial public offering of 7,500,000 units at...
Ryan Zackon, Hairmax CEO
Hairmax CEO Ryan Zackon Embarks on a Global Journey to Connect with Employees and Stakeholders
11 août 2023 08h59 HE | Hairmax
BOCA RATON, Fla., Aug. 11, 2023 (GLOBE NEWSWIRE) -- Hairmax, the pioneer and global leader in transformative hair growth, announced today that CEO Ryan Zackon has embarked on a 4-week, 22-city trip...
structure_inline_fullcolor_rgb_12in@300ppi.png
Structure Therapeutics Reports Second Quarter 2023 Financial Results and Recent Highlights
10 août 2023 16h05 HE | Structure Therapeutics Inc.
Completed enrollment in 12-week Phase 2a study of oral GLP-1 receptor agonist, GSBR-1290 Topline data from Phase 2a and Phase 1b multiple ascending dose study of GSBR-1290 expected in latter half of...